From the monthly archives:

November 2009

BronchoPhase Helps Customer With Persistent Cough

November 22, 2009 Cough

Please let your readers know that I had some kind of flu virus in mid September. It was not the swine flu and seemed to resolve in a few days except for a persistent cough. After six weeks of coughing, I took a single dose of BroncoPhase and the tightness in my chest eased and the cough almost disappeared…

Tagged as: Cough

0 comments Read more...

Study Links Boys’ Fetal Phthalate Exposure To Tendency Toward Gender-Neutral Play

November 20, 2009 News & Research

Exposures in the womb to a ubiquitous family of industrial chemicals can subtly perturb preferences of boys for certain types of child’s play thought to be hardwired in the brain, a new study suggests. Phthalates are widely used solvents and plastics softeners. In this study, the greater a boy’s fetal exposure to certain phthalates, the less often he tended to engage in typically masculine play.

0 comments Read more...

Insulin Linked to Core Body Temperature

November 20, 2009 News & Research

A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin — a hormone long associated with metabolism and metabolic disorders such as diabetes — and core body temperature. While much research has been conducted on insulin since its discovery in the 1920s, this is the first time the hormone has been connected to the fundamental process of temperature regulation.

Tagged as: Obesity

0 comments Read more...

Scientists Find Molecular Trigger That Helps Prevent Aging And Disease

November 18, 2009 Life Extension

Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction — and the reverse, overconsumption — produce protective effects against aging and disease? An answer lies in a two-part study led by Charles Mobbs, PhD, Professor of Neuroscience and of Geriatrics and Palliative Medicine at Mount Sinai School of Medicine, published…

0 comments Read more...

Connections Between Circadian And Metabolic Systems Described

November 17, 2009 Cardiovascular Research

A paper by University of Notre Dame biologist Giles Duffield and a team of researchers offers new insights into a gene that plays a key role in modulating the body’s circadian system and may also simultaneously modulate its metabolic system. The relationship between circadian and metabolic systems the researchers describe could have important implications for understanding the higher incidence of cardiovascular disease, obesity and diabetes among…

Tagged as: Heart, Obesity, Sleep

0 comments Read more...

How Exercise Changes Structure And Function Of Heart

November 16, 2009 Cardiovascular Research

For the first time researchers are beginning to understand exactly how various forms of exercise impact the heart. Massachusetts General Hospital (MGH) investigators, in collaboration with the Harvard University Health Services, have found that 90 days of vigorous athletic training produces significant changes in cardiac structure and function and that the type of change varies with the type of exercise performed. “Most of what we know…

Tagged as: Heart, Muscle

0 comments Read more...

High Fructose Corn Syrup: A Recipe For Hypertension, Study Finds

November 12, 2009 News & Research

A diet high in fructose increases the risk of developing high blood pressure (hypertension), according to a paper being presented at the American Society of Nephrology’s 42nd Annual Meeting and Scientific Exposition in San Diego, California. The findings suggest that cutting back on processed foods and beverages that contain high fructose corn syrup (HFCS) may help prevent …

Tagged as: Obesity

0 comments Read more...

Reduced Muscle Strength Associated With Risk For Alzheimer’s

November 11, 2009 Cognitive Function

Individuals with weaker muscles appear to have a higher risk for Alzheimer’s disease and declines in cognitive function over time, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals. Alzheimer’s disease is characterized by declines in memory and other cognitive (thinking, learning and memory) functions, according to background information in…

Tagged as: Brain, Muscle

0 comments Read more...

Discovery May Lead To Powerful New Therapy For Asthma

November 10, 2009 Asthma Research

University of Texas Medical Branch at Galveston researchers have found that a single enzyme is apparently critical to most allergen-provoked asthma attacks — and that activity of the enzyme, known as aldose reductase, can be significantly reduced by compounds that have already undergone clinical trials as treatments for complications of diabetes. The discovery, made in experiments conducted with mice and in human cell cultures, opens…

Tagged as: Asthma, Inflammation

0 comments Read more...

Reducing Consumption Of Glycotoxins From Heat-processing Of Foods Reduces Risk Of Chronic Disease

November 4, 2009 Cardiovascular Research

Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body’s natural defenses regardless of age or health status. The benefits of a diet lower in glycotoxins are present even without changing caloric or…

Tagged as: Heart, Inflammation

0 comments Read more...

Curry Powder Ingredient Kills Cancer Cells

November 3, 2009 Cancer

Researchers from Ireland and Poland found that curcumin, a compound found in the popular Indian spice turmeric that gives curry powder its distinct yellow colour, killed oesophageal cancer cells in the lab via an unexpected cell-death mechanism that did not involve apoptosis or cell suicide. Moreover, they found that the compound started killing cancer cells within 24 hours and…

Tagged as: Cancer, Obesity

0 comments Read more...

Promise Of A New Lupus Treatment Is A Groundbreaking Achievement

November 3, 2009 Cardiovascular Research

Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA™ (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which…

Tagged as: Heart, Immune System, Inflammation

0 comments Read more...

← Previous Entries

Next Entries →